Imatinib mesylate- an anticancer drug for CML patientsImatinib mesylate- an anticancer drug for CML patients November 15, 2023November 15, 2023| GayathriGayathri| 0 Comments | 7:59 am Drug of the week is Imatinib Mesylate, an anticancer drug. Let's look at the mode of action and current research with regard to this drug Read MoreRead More